323 studies found for:    GH1
Show Display Options
Rank Status Study
1 Unknown  Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
2 Recruiting Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
Conditions: Chronic Myelogenous Leukemia;   Short Stature
Intervention: Drug: Growth Hormone
3 Completed rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
Condition: Insulin-like Growth Factor-1 Deficiency
Interventions: Drug: NutropinAq® (Somatropin [rDNA origin]);   Drug: Increlex® (Mecasermin [rDNA origin] injection) + NutropinAq® (Somatropin [rDNA origin])
4 Completed Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction
Condition: Healthy
Interventions: Drug: GH hormone infusion;   Behavioral: 42 hour fast;   Behavioral: 12 hour fast
5 Unknown  Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
Condition: Diabetes Mellitus Type 1
Interventions: Drug: NPH insulin;   Drug: Glargine;   Drug: Detemir
6 Withdrawn Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
Condition: Idiopathic Short Stature
Intervention: Drug: Nutropin [Somatropin (rDNA origin) for injection]
7 Completed Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)
Condition: Diabetes Mellitus, Type 2
Interventions: Other: LoBag Diet - test phase;   Other: LoBAG Diet - control phase
8 Terminated
Has Results
Aralast alpha1-proteinase Inhibitor Surveillance Study
Condition: Alpha 1-Antitrypsin (AAT) Deficiency
Intervention: Drug: ARALAST Alpha1-Proteinase Inhibitor
9 Completed Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study
Condition: Spinal Cord Injury
Intervention: Drug: Baclofen
10 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
11 Completed Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
Condition: Growth Hormone Deficiency
Interventions: Drug: somatropin AQ;   Drug: pegylated somatropin
12 Completed
Has Results
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
Conditions: Kidney Failure, Chronic;   Growth Hormone Deficiency
Intervention: Drug: Nutropin AQ
13 Recruiting Growth Hormone Use in Albright Hereditary Osteodystrophy
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone
14 Completed Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat
Condition: Obesity
Interventions: Drug: Orlistat;   Other: normo-caloric diet
15 Withdrawn Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)
Condition: Acromegaly
Intervention: Drug: lanreotide (Autogel formulation)
16 Completed Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Lanreotide-Autogel 120 mg
17 Unknown  Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Condition: Traumatic Brain Injury
Interventions: Drug: Recombinant human Growth Hormone;   Drug: Placebo
18 Active, not recruiting Efficacy and Safety of Pasireotide LAR in Japanese Patients With Acromegaly or Pituitary Gigantism
Condition: Acromegaly, Pituitary Gigantism
Intervention: Drug: SOM230LAR
19 Completed Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.
Condition: SGA and Growth
Interventions: Drug: growth hormone and gonadotropin-releasing hormone agonist;   Drug: growth hormone
20 Completed An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years